Therefore, we insist that developing OPN-targeted therapy in IDD should be based on a comprehensive understanding of the biofunctions and underlying mechanisms of OPN, not only in CEP but also in other IVD tissues. The gene discussed is SPP1; the disease is intervertebral disk degenerative disorder.